Search

everythinglearnresearchcommunity

for

Search:↓

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Women without alopecia have more fat tissues and longer hair roots than those with alopecia.

People with hair loss have smaller hair roots and less fat tissue.

Stopping Seroxat (paroxetine) treatment ended hair loss in a woman.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Taking Kera-Diet® improves hair and nail health without side effects.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Lichen sclerosus et atrophicus is generally not considered precancerous, but there are exceptions.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Epinephrine does not significantly affect the severity of hair loss after surgery.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.